US Food and Drug Administration cleared Dexcom G7 15 days continuous glucose monitor (CGM) for people over the age of 18 with diabetes. It is a lasting arrangement in the market.
The G7 15 day sensor Dexcom is based on G7 CGM’s technology and work, which has proven to reduce the A1C and reduce hyper- and hypoglycemia. However it has only 10 days of lifetime. G7 15 day sensor offers can make diabetes easier to handle five additional days with low sensors for you every month.
According to Dexcom, this is also the most accurate system. The G7 15 day sensor has the overall average relative difference or MRD 8.0%. MRD measures how many times the reading from the CGM sensor is different from the blood glucose test. Dexcom G7 Sensor MRD score contains 8.2%. The sensor sends real-time glucose readings to the Dexcom G7 application every five minutes.
Uninterrupted glucose monitors have replaced fingerprints for many people and allow you to monitor the levels of sugar in your blood in real time. Dexcom is the top brand of glucose biosensing for the past 25 years. Last year, the Dexcom Stello got the FDA exemption for the first over-the-counter CGM on the Biosensor System.
This sensor can mean what to do for you
This progress is one step ahead in the management of diabetes. The five extra days of sensor life reduce the waste before you change it and give you more control over your diabetes.
You will see a number of features already available on the G7 platform such as waterproofing capabilities, automatic activities and simplified logging for your food and drugs. G7 15 Days will connect your Apple Watch to observe your glucose layer without off your phone.
The effect is not limited to your ability to track your numbers simply. You will be able to share glucose numbers with loved ones and caretakers through existing apps, though you need to be connected to the Internet in one Consistent device Sending data There is a 10-factor limit to share according to the Dexcom website. Dexcom’s precision app integration allows your doctor to see your readings, though you must Allow to share with your clinic First
FDA exemption means that Dexcom may work to ensure that G7 15 days sensor will be compatible with insulin pumps. According to the release, the G7 15-day sensor launch is expected in the second half of 2025. G7 15-day sensor will require a new prescription. The price will depend on your insurance coverage, though according to Dexcom, it should be close to the same menstrual expenditure as Dexcom G7.